Sumatriptan, 5-HT 1D receptors and obsessive-compulsive disorder

By Koran L.M.   Pallanti S.   Quercioli L.  

European Neuropsychopharmacology, Vol. 11, Iss. 2, 2001-04 ,pp. : 169-172

Elsevier

Access to resources Recommend Favorite

Zolmitriptan (a 5-HT receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder

By Boshuisen M.L.   den Boer J.A.  

Psychopharmacology, Vol. 152, Iss. 1, 2000-09 ,pp. : 74-79

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder

By Abudy Anat   Juven-Wetzler Alzbeta   Zohar Joseph  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 585-596

Adis International

Access to resources Recommend Favorite

Switch to another drug or try adjunctive therapy in patients with treatment-resistant obsessive-compulsive disorder

By  

Drugs & Therapy Perspectives, Vol. 28, Iss. 2, 2012-02 ,pp. : 14-18

Adis International

Access to resources Recommend Favorite

N-Acetyl Cysteine and Vitamin D Supplementation in Treatment Resistant Obsessive-compulsive Disorder Patients: A General Review

By  

Current Pharmaceutical Design, Vol. 24, Iss. 17, 2018-05 ,pp. : 1832-1838

Bentham Science Publishers

Access to resources Recommend Favorite